Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-05-11 @ 4:32 AM
Study NCT ID:
NCT01214733
Status:
COMPLETED
Last Update Posted:
2015-12-02
First Post:
2010-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML25321
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None